Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, November 9 2009 11:36am ET - U.S. Markets close in 4 hours and 24 minutes.
Industry Center - Drug Related Products
Industry Center > Drug Related Products > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Related Products News
View: Latest News | Top Stories
1. /C O R R E C T I O N -- Perrigo Company/ - PR Newswire - 51 minutes ago
Nov-2009 by Perrigo Company over PR Newswire, we are advised by the company that in the first paragraph, the conference date and time should read " Wednesday, November 11, at 11:00 a.m. " rather than "11:00 p.m. " as originally issued inadvertently.
2. Herbalife Chairman and CEO Implements Orderly Stock Trading Plan; Will Retain Half of Net Proceeds in Company Stock - Business Wire - 2 hours, 36 minutes ago
LOS ANGELES----Herbalife Ltd. , a global nutrition and direct-selling company, announced that Chairman and CEO Michael O. Johnson has established a pre-arranged personal stock trading plan to address the upcoming expiration of certain stock options and for asset allocation and estate planning purposes.
3. RBC Life Sciences Ranked as One of the Top 100 Workplaces in the Dallas-Fort Worth Area - PR Newswire - Mon 7:30 am ET
RBC Life Sciences, Inc. , a provider of proprietary nutritional supplements and wound care/pain management products, has been named one of the Top 100 workplaces in the Dallas-Fort Worth area.
4. Nature's Sunshine Products Reports Third Quarter Operating Results - Business Wire - Fri Nov 6
PROVO, Utah----Nature’s Sunshine Products, Inc. , a leading manufacturer and marketer of encapsulated herbs and vitamins, today reported financial operating results for the three and nine month periods ended September 30, 2009.
5. Labopharm Reports Results for Third Quarter Fiscal 2009 - PR Newswire - Fri Nov 6
Company Advances Plans to Realize the Benefits of Commercialization:
6. Prestige Brands Holdings, Inc. Reports Second Quarter & Six Months Fiscal 2010 Results - Business Wire - Thu Nov 5
IRVINGTON, N.Y.----Prestige Brands Holdings, Inc. today announced results for the second quarter and first half of fiscal year 2010, which ended on September 30, 2009.
7. Herbalife Opens New Markets in Vietnam and Paraguay - Business Wire - Wed Nov 4
LOS ANGELES----Herbalife Ltd. , a global nutrition and direct-selling company, announced that it has begun operations in Vietnam, making this the 71st country where the company conducts business.
8. Salix Pharmaceuticals to Host Analyst Day on November 18 - Business Wire - Wed Nov 4
RALEIGH, N.C.----Salix Pharmaceuticals, Ltd. today announced that the Company will host an Analyst Day on Wednesday, November 18, 2009 from 10:00 a.m. to 12:00 noon Eastern Time. A live webcast of the event will be available on the Company’s website at www.Salix.com.
9. Mannatech Reports Third Quarter Results - Business Wire - Tue Nov 3
COPPELL, Texas----Mannatech, Incorporated , a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, today reported a net loss of $9.2 million or $0.35 per diluted share for the third quarter ending September 30, 2009, compared to a net loss of $0.4 million or $0.02 per diluted share for the third quarter of 2008.
10. Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin - Business Wire - Tue Nov 3
RALEIGH, N.C.----Salix Pharmaceuticals, Ltd. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,612,199 entitled “Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin”.
Sponsor Results
RA Clinical Research
You may qualify for an RA study Participants needed in your area
www.ORALtrials.com
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today.
www.sharebuilder.com
Poly MVA - Call Toll Free
Buy 5 - 8 oz. bottles and get 1 free also shipping and special gift.
biohealthonline.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Drug Related Products Headlines
More Finance RSS Feeds


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?